Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Poland
Summary - Proceedings In The Form Of An Open Tender For The Purchase Of Drugs Under The Drug Program - Aflibercept, Ranibizumab, Farcymab And Bevacizumab
Deadline - Feb 13, 2025
GT reference number - 102414126
Product classification - Pharmaceutical products
Address - Poland
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 102414126
Document Type - Tender Notices
Description - Description: 1. The subject of the order is the purchase of drugs under the drug program - Aflibercept, Ranibizumab, Farycymab and Bevacizumab in the quantity and with the parameters specified in Appendices No. 1.1 - 1.4 to the Specification of Terms of the Order.local title:: Postępowanie w trybie przetargu nieograniczonego na zakup leków w ramach programu lekowego - Aflibercept, Ranibizumab, Farcymab i BewacyzumabContract Duration: : 12 MONTHlocal description: : 1. Przedmiotem zamówienia jest zakup leków w ramach programu lekowego - Aflibercept, Ranibizumab, Farycymab i Bewacyzumab w ilości i o parametrach określonych w Załącznikach nr 1.1 – 1.4 do Specyfikacji Warunków Zamówie
Gt Ref Id - 102414126
Deadline - Feb 13, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database